Ketamine For Suicidal Ideation

• Status: Completed
• Trial end date: 2014-09-01

Summary

This study will examine the effects of Intravenous (IV) ketamine both in an outpatient population and with subjects on the inpatient unit with suicidal ideation (SI).

• Phase: Phase 4

Details

• Lead Sponsor: James Murrough
• Treatments: Excitatory Amino Acid Antagonists; Ketamine; Midazolam; N-Methylaspartate